Dendritic cells in cancer vaccines

This publication has 107 references indexed in Scilit:

• Synthetic insertion signal sequences enhance MHC class I presentation of a peptide from the melanoma antigen MART-1
  European Journal of Immunology, 2000
• RelB Is Essential for the Development of Myeloid-Related CD8α− Dendritic Cells but Not of Lymphoid-Related CD8α+ Dendritic Cells
  Immunity, 1998
• Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice
  Journal of Surgical Oncology, 1998
• Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells
  Human Immunology, 1997
• Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
  The Journal of Experimental Medicine, 1996
• Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
  The Journal of Experimental Medicine, 1996
• Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.
  The Journal of Experimental Medicine, 1994
• GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
  Nature, 1992
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• The Dendritic Cell System and its Role in Immunogenicity
  Annual Review of Immunology, 1991